Case Report: A rare case of hemoptysis: multiple vascular variations.

IF 3.1 3区医学 Q1 MEDICINE, GENERAL & INTERNAL

Frontiers in Medicine Pub Date : 2025-06-05 eCollection Date: 2025-01-01 DOI:10.3389/fmed.2025.1585686

Beining Zhang, Jiangye Wang, Ninggang Zheng

引用次数: 0

Abstract

Bronchial artery embolization (BAE) is an effective treatment for hemoptysis, with potential complications including pain and spinal ischemia. We report a rare case in which the right bronchial artery communicated with the right intercostal arteries, and the right intercostal artery had an anastomosis with the right vertebral artery. Additionally, the left bronchial artery was found to have a connection with the left vertebral artery.

查看原文本刊更多论文

病例报告：1例罕见咯血：多血管变异。

支气管动脉栓塞（BAE）是治疗咯血的有效方法，但其潜在的并发症包括疼痛和脊髓缺血。我们报告一例罕见的右支气管动脉与右肋间动脉相通，右肋间动脉与右椎动脉吻合。此外，发现左支气管动脉与左椎动脉有连接。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Frontiers in Medicine Medicine-General Medicine

CiteScore

5.10

自引率

5.10%

发文量

3710

审稿时长

12 weeks

期刊介绍： Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate - the use of patient-reported outcomes under real world conditions - the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines - the scientific bases for guidelines and decisions from regulatory authorities - access to medicinal products and medical devices worldwide - addressing the grand health challenges around the world